HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Risk Stratification Scheme for In-Hospital Cardiogenic Shock in Patients With Acute Myocardial Infarction.

AbstractObjective:
Cardiogenic shock (CS) is the leading cause of death in patients with acute myocardial infarction (AMI) despite advances in care. This study aims to derive and validate a risk score for in-hospital development of CS in patients with AMI.
Methods:
In this study, we used the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) registry of 76,807 patients for model development and internal validation. These patients came from 158 tertiary hospitals and 82 secondary hospitals between 2014 and 2019, presenting AMI without CS upon admission. The eligible patients with AMI were randomly assigned to derivation (n = 53,790) and internal validation (n = 23,017) cohorts. Another cohort of 2,205 patients with AMI between 2014 and 2016 was used for external validation. Based on the identified predictors for in-hospital CS, a new point-based CS risk scheme, referred to as the CCC-ACS CS score, was developed and validated.
Results:
A total of 866 (1.1%) and 39 (1.8%) patients subsequently developed in-hospital CS in the CCC-ACS project and external validation cohort, respectively. The CCC-ACS CS score consists of seven variables, including age, acute heart failure upon admission, systolic blood pressure upon admission, heart rate, initial serum creatine kinase-MB level, estimated glomerular filtration rate, and mechanical complications. The area under the curve for in-hospital development of CS was 0.73, 0.71, and 0.85 in the derivation, internal validation and external validation cohorts, respectively.
Conclusion:
This newly developed CCC-ACS CS score can quantify the risk of in-hospital CS for patients with AMI, which may help in clinical decision making.
Clinical Trial Registration:
www.ClinicalTrials.gov, identifier: NCT02306616.
AuthorsJun-Qing Yang, Peng Ran, Jie Li, Qi Zhong, Sidney C Smith Jr, Yan Wang, Gregg C Fonarow, Jia Qiu, Louise Morgan, Xue-Biao Wei, Xiao-Bo Chen, Jie-Leng Huang, Yong-Chen Hao, Ying-Ling Zhou, Chung-Wah Siu, Dong Zhao, Ji-Yan Chen, Dan-Qing Yu
JournalFrontiers in cardiovascular medicine (Front Cardiovasc Med) Vol. 9 Pg. 793497 ( 2022) ISSN: 2297-055X [Print] Switzerland
PMID35310985 (Publication Type: Journal Article)
CopyrightCopyright © 2022 Yang, Ran, Li, Zhong, Smith, Wang, Fonarow, Qiu, Morgan, Wei, Chen, Huang, Hao, Zhou, Siu, Zhao, Chen and Yu.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: